Abbisko Cayman Ltd
HKEX:2256
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Panasonic Manufacturing Malaysia Bhd
KLSE:PANAMY
|
MY |
Abbisko Cayman Ltd
Other
Abbisko Cayman Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Abbisko Cayman Ltd
HKEX:2256
|
Other
-¥1.6m
|
CAGR 3-Years
49%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Other
-¥166.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Other
¥75.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Other
-¥107.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Other
-¥138.9m
|
CAGR 3-Years
-138%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Other
-¥2.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbisko Cayman Ltd
Glance View
Abbisko Cayman Ltd. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of drugs and small molecule oncology therapies. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-10-13. The firm is dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The firm owns two Core Product Candidates, ABSK011 and ABSK091, and 12 other pipeline product candidates. ABSK011 is a potent and highly selective small molecule inhibitor of fibroblast growth factor receptor 4 (FGFR4). ABSK091 is a molecularly targeted product candidate and a highly potent and selective inhibitor of FGFR subtypes 1, 2 and 3. The Company’s products are primarily being developed for hepatocellular carcinoma (HCC), urothelial cancer (UC) and gastric cancer (GC).
See Also
What is Abbisko Cayman Ltd's Other?
Other
-1.6m
CNY
Based on the financial report for Dec 31, 2025, Abbisko Cayman Ltd's Other amounts to -1.6m CNY.
What is Abbisko Cayman Ltd's Other growth rate?
Other CAGR 5Y
-37%
Over the last year, the Other growth was 0%. The average annual Other growth rates for Abbisko Cayman Ltd have been 49% over the past three years , -37% over the past five years .
